NCT04387084 2026-03-23
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
University of Southern California
Phase 1 Active not recruiting
University of Southern California
University Health Network, Toronto
DEKA Biosciences
Bristol-Myers Squibb
BioNTech SE